|
OUR PARTNERS | |||||||||||||
Individually Randomized Trial of Rapid Diagnostic Tests in Rural |
![]() |
|||||||||||||
Introduction The study begun in the first quarter of 2007 with baseline studies and recruitment for the main trial was completed in December 2008. Activities in the year under review will focus mainly on the last two of the five specific objectives as follows: • To explore clinician and patient perceptions on the use of RDTs, microscopy and clinical diagnosis in the management of malaria. • To determine the cost-effectiveness of RDTs for diagnosis of malaria in both settings. Study Sites Four health facilities sited in three communities participated in these two phases of the study. These were the same health facilities that were involved in the main trial. Microscopy (‘M’) setting – Dodowa Health Centre (DHC) Clinical (‘C’) setting – Agomeda Community Clinic (ACC) Prampram Health Centre (PHC) Ebenezer Private Clinic (EPC)
Data Cleaning And Analysis The main RDT trial data was extensively cleaned and all errors rectified. The data was analyzed together with co-investigators from London School of Hygiene and Tropical Medicine. Reports were written and a paper produced for publication. This was subsequently accepted for publication by the British Medical Journal (BMJ). Qualitative Study The Qualitative study which aimed at exploring both patient and clinician perceptions on the use of
Cost Effectiveness Study The cost-effectiveness phase which was aimed at determining the cost-effectiveness of introducing Data collection for the cost-effectiveness phase of the study has just been completed. The data collection involved carrying out randomization of patients as occurred in the main trial. The following were done: • Documentation of the socio-economic status of patients receiving primary care for malaria in two settings where RDTs have been introduced: where there is microscopy and where there is none • Documentation of both the direct and indirect costs of care in both settings The work was supported by the two health economists who are core scientists on the ACT consortium one of who travelled to Ghana to assist in the data collection and preliminary analysis. Additional data had to be collected on time health staff allocate to laboratory tests to validate data previously collected. Follow-up of the patients also took place from 7th September to 14th October 2009. A mop up exercise was undertaken for one week and this ended on 21st October, 2009. The data has been cleaned and verified and is now being analyzed. |
||||||||||||||